Neuromodulatory Approaches for Atrial Fibrillation Ablation-Reference-Cited by-同舟云学术

Neuromodulatory Approaches for Atrial Fibrillation Ablation

Published:2021-12-09 Issue: Volume:16 Page:
ISSN:1758-3764
Container-title:European Cardiology Review
language:en
Short-container-title:Eur Cardiol

Author:

Rodríguez-Mañero Moisés¹^ORCID,Martínez-Sande Jose Luis¹,García-Seara Javier¹,González-Ferrero Teba²,González-Juanatey José Ramón¹,Schurmann Paul³,Tavares Liliana³,Valderrábano Miguel³

Affiliation:

1. Department of Cardiology, University Hospital of Santiago de Compostela, Santiago de Compostela, A Coruña, Galicia, Spain; Institute of Health Research, University of Santiago de Compostela, Santiago de Compostela, A Coruña, Galicia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain

2. Department of Cardiology, University Hospital of Santiago de Compostela, Santiago de Compostela, A Coruña, Galicia, Spain

3. Methodist DeBakey Heart and Vascular Center and Methodist Hospital Research Institute, The Methodist Hospital, Houston, TX, US

Abstract

In this review, the authors describe evolving alternative strategies for the management of AF, focusing on non-invasive and percutaneous autonomic modulation. This modulation can be achieved – among other approaches – via tragus stimulation, renal denervation, cardiac afferent denervation, alcohol injection in the vein of Marshall, baroreceptor activation therapy and endocardial ganglionated plexi ablation. Although promising, these therapies are currently under investigation but could play a role in the treatment of AF in combination with conventional pulmonary vein isolation in the near future.

Publisher

Radcliffe Group Ltd

Subject

Cardiology and Cardiovascular Medicine

Reference53 articles.

1. Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol 2013;112:1142–7. https://doi.org/10.1016/j.amjcard.2013.05.063; PMID: 23831166.

2. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130:e199–267. https://doi.org/10.1161/CIR.0000000000000041; PMID: 24682347.

3. Armour JA. Functional anatomy of intrathoracic neurons innervating the atria and ventricles. Heart Rhythm 2010;7:994–6. https://doi.org/10.1016/j.hrthm.2010.02.014; PMID: 20156593.

4. Stavrakis S, Po S. Ganglionated plexi ablation: physiology and clinical applications. Arrhythm Electrophysiol Rev 2017;6:186–90. https://doi.org/10.15420/aer2017.26.1. https://doi.org/10.15420/aer2017.26.1; PMID: 29326833.

5. Po SS, Nakagawa H, Jackman WM. Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2009;20:1186–9. https://doi.org/10.1111/j.1540-8167.2009.01515.x; PMID: 19563367.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epicardial adipocytes in the pathogenesis of atrial fibrillation: An update on basic and translational studies;Frontiers in Endocrinology;2023-03-20